NCT04021914

Feasibility of EnChroma Use in the Emergency Department Setting

Demonstrating Feasibility of Color Vision Deficient Provider Use of EnChroma Products in the Emergency Department

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 6 (actual)
• Sponsor: Emory University · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study addresses whether the use of EnChroma products are feasible for use in the emergency department by color vision deficient providers.

Detailed description

This study addresses whether it is feasible for color vision deficient (CVD) physicians and other healthcare providers to wear EnChroma products in the clinical setting. It is known that color vision is important to the practice of medicine. Identifying red skin or red ear drums, noticing whether lips have turned blue or a patient is pale, and identifying colors under a microscope all are aided by or dependent upon color vision. While color vision deficiency does not preclude a person from becoming and succeeding as a physician, it may be appropriate and desired to utilize devices to improve color vision during patient care.

Conditions

• Color Vision Defects

Interventions

Type	Name	Description
DEVICE	EnChroma glasses	Each participant will be provided EnChroma products to use indoors over the course of two weeks in the emergency department, educational settings, and in their personal life. They will be encouraged to wear the glasses for at least 10 hours over 1-2 weeks prior to wearing them in a clinical setting to adjust to their use, and for 10 minutes before beginning patient care as per manufacturer instructions. They will be encouraged to take specific note of clinical scenarios that require the use of color vision (e.g., - rashes, tympanic membrane erythema, stool guaiac testing, etc.).

Timeline

• Start date: 2019-08-14
• Primary completion: 2023-03-15
• Completion: 2023-03-15
• First posted: 2019-07-16
• Last updated: 2023-09-18
• Results posted: 2023-09-18

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study